We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bluwater Bio | LSE:BWB | London | Ordinary Share | KYG119491077 | ORD 0.5P (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
14/11/2008 12:08 | ted32....think they think can operate more effectively without quote and i do not necessarilly disagree...aim is dead for quite a while and can be a major distraction to management. anyway this was the news he alighted to...not bad! Bluewater Bio Intnl Signs 5yr Deal With Grupo Unit Aqualia Friday November 14th, 2008 / 9h24 Edited Press Release LONDON -(Dow Jones)- Bluewater Bio International, has signed a five-year binding agreement with Aqualia Gestion Integral del Agua, a subsidiary of global infrastructure giant Grupo. Grupo manages water and wastewater related projects in over 850 municipalities on five continents, serving over 26 million people. Bluewater Bio has developed a proprietary technology, Hybrid Bacillus Activated Sludge, a biological wastewater treatment process that is odourless and that produces a high quality, re-usable effluent. HYBACS reduces operational expense, primarily electricity consumption, by up to 50%. Furthermore, due to its compact modular footprint, HYBACS can either halve the land requirement or increase the treatment capacity of an existing works, thereby significantly reducing build cost. Under the agreement, Bluewater Bio will install a proprietary HYBACS plant at a municipal site in Avila. The plant will be operated by Aqualia, using the Company's HYBACS wastewater treatment process for enhanced nutrient control at a land-constrained facility. The plant will be installed at the site within 8-10 weeks, whereupon commissioning will commence. In addition the Company has appointed Aqualia as its sole representative in Spain for the sale of HYBACS technology, a market where wastewater re-use is becoming a critical geo-political issue. The term of the agreement is five years, subject to Aqualia achieving certain sales milestones by the third and fourth anniversaries of the agreement. Friday November 14th, 2008 / 9h24 Source : | kooba | |
13/11/2008 10:31 | kooba ceo was indeed very upbeat.He also said that there was no problem with funding. Why, in that case, delist the shares? | ted32 | |
13/11/2008 09:54 | ceo on bloomberg this am,i know it's been delisted but was v upbeat and they are to announce significant contract this p.m. apparently with sixth biggest water co in world.maybe there is life in the old dog yet.lets hope they remember the p.i. shareholders. | kooba | |
09/10/2008 14:39 | Think most investors have been burnt at one time or another by an AIM listed share. I for one will never invest in this junior market again, BOD's can get away with murder! | pictureframe | |
08/10/2008 14:44 | Delisting. Looks like they need funds and can't get them from the statement. Management don't seem to me to have had any easily discernible or consistent strategy as far as I can see - except to raise more and more money! | egoi | |
19/9/2008 09:53 | Shares magazine vaguely mentioned BWB yesterday. They also mentioned Modern Water, which is a recent float on AIM. | arf dysg | |
15/8/2008 08:47 | problem is they're burning through it too quickly - working capital raised on admission not sufficient - overheads obviously too high for a startup which hasn't done any deals since listing!!! nick | n1ck_leeson | |
11/8/2008 17:27 | ...so what's the problem? Company needs cash, company raises cash. End of problem. I like the fact that Lehman Brothers are investors and have increased their investment. | arf dysg | |
30/7/2008 07:23 | spot on then!! | n1ck_leeson | |
29/7/2008 08:27 | UHUH Good source !!!! They just raised two million pounds | clancrackan | |
24/7/2008 16:46 | be warned people - i heard a rumour that they're about to run out of cash - good source as well | n1ck_leeson | |
10/6/2008 12:06 | Well the facts that until MT Glass posted yesterday, no one had posted since riptracker's post last year and that by May 2008 BWB share price had fallen to 4.26p to buy, caused me to have a look. No revenue stream stats. is the main worry but the need for and ethical/green nature of its services seem clear. I bought a few at the begining of May at 4.26p and topped up later that month at 5.50p. Since then there has been some buying and sufficient share price gains to put my Bluewater Bio holdings in the blue (lol) ALl imho so dyor | maytrees | |
09/6/2008 16:15 | BWB is already among the dozen water stocks listed on the H2O thread But if anyone can think of other UK water stocks that ought to be added, please mention them there. | m.t.glass | |
21/12/2007 12:51 | Carefull with this stock, as a similar company did not perform. Also theres a good reason why the price at this level as the traders sold of this stock after the IPO down 36%. It takes a long time after floation especially with small caps. So tread gently as this may retract to a lower level for obvious reasons.! | riptracker | |
20/12/2007 23:15 | Shares Mag 2008 Blue Sky punts... (price is now well below the stop loss even though the tip only came out today!) BLUEWATER BIO (BWB:AIM) 13p, stop loss 10p The absence of a track record of revenues may make Bluewater a risky play, but with innovative, well-tested technology and large potential market it's very easy to see the upside. Vital stats: Market value: £28 million Historic PE 2007: n/a Prospective PE 2008: n/a Prospective PE 2009: n/a Sector PE: 13.9 1-month relative strength: n/a 1-year relative strength: n/a Yield: n/a NMS: n/a Spread: 7.4% Newly-floated Bluewater Bio brings a clever technology opportunity to the junior market - one that has already been successfully tested and is operational in South Korea. It also comes with six years of data that demonstrates its worth. HYBACS, the company's flagship waste-water treatment technology, is based on bacteria that eat the waste component in waste-water. Such systems already exist but HYBACS, which was developed by specialists Yeon Je Cho and Garry Hoyland, who are part of the management team, has some huge advantages. While in common bacteria processes bacteria are poured in the dirty water and left eating the dirt, Bluewater's multi-phase process system controls the life cycle of the bacteria by changing some elements of the environment where they live. Wastewater is sent through the HYBACS units and at the last stage of the process, when the bacteria's cleaning work is done, the system sends them 'to sleep' and carries them back to the start. This means the units can save corporations and utilities up to 15% in capital expenditure and a huge 30% in operational costs. They can be installed within any treatment systems, using up to 90% of the existing infrastructure, and taking up little space. As much as 50% less energy is needed over the lifetime of the plants. The unit's efficiency is huge, as the system can remove up to 99% of biological contamination from concentrated wastewater, and cleaner water can be reused, making companies' water bill lighter. CEO Daniel Ishag says that soon there should be news about deals with major European corporations for the sale of the units. It is a risky punt, as the company doesn't have a track record of revenues, but the potential market is huge, as other wastewater treatment methods are not nearly as efficient. On that basis, interest should send the shares up quickly. | stegrego | |
14/12/2007 00:26 | Interesting Particularly like the fact the CEO is called 'Ishag' | stegrego | |
13/12/2007 10:16 | - - - - - - Raised £2.775 million in 12.5p placing (22.2m shares) to repay loans, working capital, continue R&D; mkt.cap £27m. Already operating in 22 sites S. Korea, covering many different types of effluent. Pre-admission news [ 10dec07 - Bloomberg interview on the above page 25nov07 - Sunday Times - 22nov07 - Shares Magazine - 20nov07 - Evening Standard - 19nov07 - Daily Expres - | mikehardman | |
29/11/2004 17:03 | Have created a thread under the new shortened name (and diff epic) of Burtonwood See: | abcd1234 | |
29/11/2004 17:03 | Have created a thread under the new shortened name (and diff epic) of Burtonwood See: | abcd1234 | |
29/11/2004 17:02 | Have created a thread under the new shortened name (and diff epic) of Burtonwood See: | abcd1234 | |
25/8/2004 17:59 | on 10/6 go for quote then look right hand box and it lists all the posts, if you look at this stocks volumes every now and then some very strange trades occur i am sure that someone is stake building for a bid or indeed maybe it is going private either way a bid looks likely, why one of the other pub chains have missed it is beyond me! | 1mainman | |
19/8/2004 15:45 | Where is this previous posting? I cannot see it. Perhapts its because I've not paid for the full ADVFN service? Thanks | bravil | |
19/8/2004 08:11 | see my previous postings | 1mainman | |
17/8/2004 12:42 | A recent post on Ample suggested that there have been boardroom 'wranglings' and that this firm may go private soon. Does anyone have any further information on this? buy/sell/hold? | bravil |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions